議程

第1天 2020年2月27日(四)

8:15

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Justus Chua
Head of Legal and Compliance – South East Asia & South Korea
Boehringer Ingelheim (Singapore)

8:40

A Brief History of Ethics & Compliance in Japan

Katsumi Kojima
Regional Compliance Director North Asia
Abbott (Japan)
International Ethics Promotional Working Group Leader
Japan Federation of Medical Devices Associations (JFMDA)
Visiting Lecturer
Kyoto Prefectural University of Medicine (Japan)

9:00

EXPERT Q&A Building in Ethics and Integrity at the Heart of Compliance

AN INTERVIEW WITH:

Justus Chua
Head of Legal and Compliance – South East Asia & South Korea
Boehringer Ingelheim (Singapore)

Yutaka Mitsutake
Compliance Business Partner
AstraZeneca K.K. (Japan)

End-to-End Compliance —
Risk Assessments to Audits & Investigations

9:45

CASE STUDY Risk Assessment and Mitigation with Shared Resources and Automation

Xuan Anh Nguyen
Head of Ethics and Business Integrity – Vietnam/Indochina
Sanofi-Aventis (Vietnam)

10:30

Networking and Refreshment Break

11:00

Applying Lessons from Internal Investigations to Risk Assessments

Brian Caster
Senior Director, Compliance Investigations, APAC Region
Pfizer (Japan)

Mari Hiraizumi
General Counsel and Head of Compliance, Japan
GlaxoSmithKline (Japan)

Anti-Corruption and
Third-Party Risk Management

11:45

CO-PRESENTATION Examine Strategies for Conducting Due Diligence on Third-Parties and Distributors

Tali Guy
Vice President of Compliance,
Third Party Due Diligence & Global R&D Compliance Officer
Teva Pharmaceuticals (Israel)

Naveen Bhardwaj
Senior Counsel - Legal & Compliance
Terumo Corporation (Japan)

12:30

Networking Luncheon

13:45

Beyond Due Diligence —
Managing the Relationship with Co-Promotion Partners

Yoo-Kyung (Karen) Choi
Compliance Director, Corporate Compliance
Pfizer Pharmaceuticals Korea Ltd. (South Korea)

Country Updates

14:30

Navigate the Complex Regulatory Landscape in China

Speaker TBA

15:15

Networking and Refreshment Break

15:45

BENCHMARKING SESSION Examine the Current Environment of Drug Promotion in Japan

Kinichi Enomoto
Country Compliance Lead
Pfizer Holdings (Japan)

Hiroyuki Fukumori
Director, Corporate Compliance
Taiho Pharmaceutical Co., Ltd. (Japan)

Transparency

16:30

PANEL DISCUSSION A Spotlight on the Challenges and Opportunities Reshaping Transparency Reporting

MODERATOR:

Ben Carmel
Senior Director
IQVIA Commercial Compliance (United States)

PANELISTS:

Hiroyuki Fukumori
Director, Corporate Compliance
Taiho Pharmaceutical Co., Ltd. (Japan)

Koichiro Miyata
Senior Director and General Counsel
Medtronic (Japan)

Katharina Graisy
Global Compliance Manager
GE Healthcare (Japan)

17:15

Close of Day One

Networking, Wine
and Cheese Reception
immediately following the final session

第2天 2020年2月28日(五)

8:00

Morning Refreshments

8:30

Chairman’s Review of Day One

Justus Chua
Head of Legal and Compliance – South East Asia & South Korea
Boehringer Ingelheim (Singapore)

HCP and Patient Interactions

8:45

Current MedTech and Pharmaceutical Guidelines for HCP Interactions

Asif Usmani
Regional Franchise & FEM Compliance Head, APAC
Alcon Pte Ltd (Singapore)

9:30

PANEL DISCUSSION Managing Risky Activities — Speaker Programs, Disease Awareness Programs, Charitable Contributions and More

MODERATOR:

Matthew Gallo
Director, Global Solution Enablement
IQVIA Commercial Compliance (United States)

PANELISTS:

Catherine Healy Kanzler
Head of Global Compliance Operations
Olympus Corporation

Kinichi Enomoto
Country Compliance Lead
Pfizer Holdings (Japan)

10:15

Networking and Refreshment Break

Medical Affairs and Medical Science Liaison (MSL) Oversight

10:45

Keeping Up with Key Issues in Medical Affairs Compliance

Kunio Kawajiri
Associate Director, Healthcare Compliance, Ethics & Compliance
Astellas Pharma Inc. (Japan)

Yang Hee Lee
Director and Head, Ethics & Compliance Officer, Japan
GlaxoSmithKline (Japan)

Asia-Pacific Economic Cooperation (APEC) News

11:30

10 Years Later – An Update on the Business Ethics for APEC SMEs Initiative

Katsumi Kojima
Regional Compliance Director North Asia
Abbott (Japan)
International Ethics Promotional Working Group Leader
Japan Federation of Medical Devices Associations (JFMDA)
Visiting Lecturer
Kyoto Prefectural University of Medicine (Japan)

12:15

Networking Luncheon

Data Protection in the Age of
Connected Healthcare

13:15

PANEL DISCUSSION Data Privacy and Cybersecurity —
What Every Compliance Professional Needs to Know

MODERATOR:

Tom Chan
Head of Legal, Greater China
Takeda (China) Holdings Co., LTD

PANELISTS:

Agatha L. O’Malley
Global Data Protection Officer
Otsuka Pharmaceutical, Inc. (United States)

Aki Sudo
Director, Compliance and Risk Management
Otsuka Pharmaceutical, Inc. (Japan)

Fay Li
Director, Ethics & Compliance, Greater China & Japan
BD (China)

Disruptive Technologies and
Strategies Impacting Compliance

14:00

Transforming Healthcare Compliance in the Age of Digital Disruption

Maria (Maru) Quindimil
Executive Director, JAPAC Regional Compliance
Amgen (Hong Kong)

Jonathan Shun Wah
Assistant General Counsel – Greater China & APAC, Investigations Lead
Pfizer Inc (China)

14:45

Close of Conference

* 活動內容有可能不事先告知作更動及調整。